Karius Secures $100M to Expand Non-Invasive Pathogen Blood Test
What You Should Know:
– Karius®, a leader in genomic diagnostics for infectious disease, announced today the closing of a $100 million Series C funding round.
– Co-led by Khosla Ventures and newcomers 5AM Ventures and…
Continue Reading